Dempze Nancy E Medtronic PLC Transaction History

Dempze Nancy E

$162 Million
Q3 2024

A detailed history of Dempze Nancy E transactions in Medtronic PLC stock. As of the latest transaction made, Dempze Nancy E holds 7,143 shares of MDT stock, worth $615,798. This represents 0.4% of its overall portfolio holdings.

Number of Shares

7,143

Previous 17,234 58.55%

Holding current value

$615,798

Previous $1.36 Million 52.58%

% of portfolio

0.4%

Previous 1.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$76.84 - $91.03 $775,392 - $918,583	-10,091 Reduced 58.55%	7,143 $643,000
Q2 2024 Aug 12, 2024	SELL	$78.71 - $87.02 $5,509 - $6,091	-70 Reduced 0.4%	17,234 $1.36 Million
Q1 2024 May 13, 2024	BUY	$82.84 - $88.09 $146,626 - $155,919	1,770 Added 11.39%	17,304 $1.51 Million
Q4 2023 Feb 13, 2024	BUY	$69.43 - $83.43 $18,398 - $22,108	265 Added 1.74%	15,534 $1.28 Million
Q3 2023 Nov 14, 2023	BUY	$78.22 - $90.4 $108,334 - $125,204	1,385 Added 9.98%	15,269 $1.2 Million
Q2 2023 Aug 14, 2023	BUY	$79.47 - $91.38 $197,959 - $227,627	2,491 Added 21.86%	13,884 $1.22 Million
Q1 2023 May 10, 2023	BUY	$76.72 - $87.58 $239,136 - $272,986	3,117 Added 37.66%	11,393 $918,000
Q4 2022 Feb 09, 2023	SELL	$76.18 - $87.74 $124,401 - $143,279	-1,633 Reduced 16.48%	8,276 $643,000
Q3 2022 Nov 08, 2022	BUY	$80.75 - $95.31 $231,429 - $273,158	2,866 Added 40.69%	9,909 $800,000
Q2 2022 Jul 19, 2022	BUY	$87.4 - $113.09 $311,668 - $403,278	3,566 Added 102.56%	7,043 $632,000
Q1 2022 May 17, 2022	BUY	$100.58 - $112.38 $349,716 - $390,745	3,477 New	3,477 $386,000

Others Institutions Holding MDT

# of Institutions

2,285

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dempze Nancy E, based on Form 13F filings with the SEC.

News

Stay updated on Dempze Nancy E with notifications on news.

Account